Search Login Register

Leukoencephalopathies Summary

Description: Any of various diseases affecting the white matter of the central nervous system.

Also Known As: White Matter Diseases; Disease, White Matter; Diseases, White Matter; White Matter Disease; Childhood Ataxia with Diffuse Central Nervous System Hypomyelination Show All >>

Networked: 1001 relevant articles (22 outcomes, 45 trials/studies) for this Disease

Key Drugs and Agents for Leukoencephalopathies

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Methotrexate (Mexate) : 3 outcomes 3 studies in 102 results : FDA 8 Generic
  2. Leucovorin (Folinic Acid) : 2 outcomes in 10 results : FDA 6
  3. Protons (Proton) : 1 outcome 2 studies in 17 results : IBA
  4. Heroin (Diamorphine) : 1 outcome 1 study in 54 results : IBA
  5. Carbon Monoxide : 1 outcome 1 study in 14 results : IBA
  6. Tegafur : 1 outcome 1 study in 5 results : IBA
  7. Laminin (Merosin) : 1 outcome 1 study in 3 results : IBA
  8. Factor IX (PTC) : 1 outcome 1 study in 2 results : FDA 2 Generic
  9. Tacrolimus (Prograf) : 1 outcome in 26 results : FDA 7 Generic
  10. Cyclosporine (Ciclosporin) : 1 outcome in 24 results : FDA 20 Generic
Show All >>

Diseases Related to Leukoencephalopathies

  1. Stroke (Strokes)
  2. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
  3. Cerebral Hemorrhage
  4. Brain Neoplasms (Brain Tumor)
  5. Hydrocephalus (Hydrocephaly)
Show All >>

Key Therapies for Leukoencephalopathies

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 5 outcomes 3 studies in 93 results
  2. Ventriculoperitoneal Shunt : 1 outcome 1 study in 1 result
  3. Plasmapheresis : 1 outcome in 3 results
  4. Activities of Daily Living (ADL) : 1 outcome in 1 result
  5. Radiotherapy : 1 study in 27 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.